http://www.medpagetoday.com
Steven E. Nissen, M.D., of the Cleveland Clinic
CHICAGO -- The diabetes drug pioglitazone (Actos) led to a significant slowing of atherosclerosis, albeit small, as measured by intravascular ultrasound (IVUS), compared with glimepiride, researchers said here today.
Link to this comment:
All Comments (0)